Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiovascular disease caused thereby

摘要

Compositions and methods for preventing or treating cardiac hypertrophy which inhibit the cardiac hypertrophy signal pathway mediated through G protein coupled receptors (GPCR) or epidermal growth factor (EGF) receptors. The present invention also relates to methods for screening active ingredients, and to animal models of cardiac hypertrophy.